Opportunities and Challenges in China's Biopharmaceutical Innovation: SAPA 2021 China Annual Conference
October 14-15, 2021 · Suzhou High-Tech Zone, China
The “Opportunities and Challenges in the Development of China’s Biopharmaceutical Industry & SAPA 2021 China Annual Conference,” hosted by the Sino-American Pharmaceutical Professionals Association – China (SAPA-China) and guided and co-organized by the Administrative Committee of Suzhou New District and the Administrative Committee of Suzhou Xushuguan Economic and Technological Development Zone, will be grandly held in Suzhou New District on October 14–15, 2021. More than 1,500 attendees are expected, including scholars from leading global research institutions and executives from major multinational pharmaceutical and biotechnology innovation companies. The conference will feature a series of activities such as high-level forums, thematic sessions, project matchmaking, financing promotions, and corporate exhibitions, focusing on topics including the ecosystem of China’s pharmaceutical and biotechnology development, strategies for promoting drug innovation, and cutting-edge scientific technologies. This event will serve as an international academic gathering connecting the entire biopharmaceutical industry chain—from source innovation, applied research, and clinical development to manufacturing and sales—and provide an excellent platform for the integration of capital and projects.
SAPA is the most active and largest Chinese-led professional organization in the biopharmaceutical sector in North America. With a 28-year history, it currently boasts over 6,000 members worldwide. The association’s mission is to advance the development of biopharmaceutical science and technology, promote industrial investment and business collaboration, popularize public health education, and support and facilitate the career development of its members. Headquartered in the New Jersey–Greater New York area of the United States, SAPA also maintains chapters in the New England region (Boston NE), the Greater Philadelphia area (Philadelphia GP), Washington D.C. (DC), Connecticut (CT), the Midwest (Chicago MW), and China. SAPA members’ expertise spans the entire ecosystem of biopharmaceutical product research and development, manufacturing, commercialization, international cooperation, financing, and public listing. Their professional fields include target identification and development for innovative drugs; preclinical and clinical druggability studies; process development and manufacturing of small-molecule chemical drugs and large-molecule biologics; regulatory registration and filing for market access; commercial marketing and sales; and R&D and production technologies for generic drugs.
Since its establishment, SAPA has built a robust platform for international exchange in the pharmaceutical industry. It has made significant contributions to promoting technical training, talent development, and business collaboration between multinational corporations and local enterprises. SAPA has earned a strong reputation and widespread respect in both North America and China, serving as a premier platform for communication within the Chinese and American pharmaceutical sectors and for interaction among industry elites. For more information about SAPA, please visit www.sapaweb.org. We sincerely invite you to attend this prestigious event and look forward to meeting you in Suzhou!
Dr. Hu Jiangbin, President of SAPA China
SAPA China 2021 Annual Conference Organizing Committee
Scan the QR Code for Quick Registration
(The conference organizing committee will contact you within 24 hours)
● Conference & Exhibitor Inquiries:
Mr. He +86 189 1895 8744
Email: hezhengshen@shengjiejituan.cn
● Conference Inquiry:
Teacher Xie +86 150 6123 2737
Email: xiewenbo@shengjiejituan.cn
● Media Collaboration:
Ms. Wang +86 178 2171 2008
Email: wangyujia@shengjiejituan.cn